SARS-CoV-2 has dominated most discussions about laboratory shortages during the pandemic, but facilities have also struggled to secure supplies for more routine testing.
The medical director of lab information technology at Yale-New Haven Hospital, Durant has published a paper on information sharing challenges during the pandemic.
Ortho said it intends to use the net proceeds from the offering to redeem senior notes and repay borrowings under its dollar term loan facility, among other uses.
Within its diagnostics division, the firm posted molecular diagnostics revenue of $995.3 million, up more than fivefold from $178.5 million in fiscal Q1 2020.
The test uses primers and probes from Thermo Fisher Scientific's authorized TaqPath COVID-19 Combo Kit with a modified results interpretation algorithm.
Talis, a point-of-care test developer, said that the principal purpose for the offering is to obtain additional capital to support its operations, among other purposes.
FIND said it will announce agreements that will enable the distribution of more than 250 million rapid antigen tests per year to low- and middle-income countries.
The administration has proposed steps such as funding increased production of testing supplies and ensuring schools have access to more frequent testing.
